Opinions Jim Cramer - Mad Money
Meta Platforms IncMETABUYMar 15, 2023
Jim Cramer - Mad MoneyStock price when the opinion was issued
As of Oct 05, 2026. Market Open.
You might be interested:
In the last quarterly report they beat on numbers and showed strong revenue growth which it's not getting credit for. How to monetize AI is the big issue but it is showing that it can be productive on the AI side. They are seeing clearly the benefits of AI in their advertising business model. The market had undervalued it but it is now trading at a premium. It still can go up if they can execute well.
Buy 72 Hold 6 Sell 1
Paul Harris, CFAHuge fan of it. The consumer will drive the stock, now that they released the Muse AI agent targeting consumers. He is selling covered calls on Meta. Great to see the founder mature into a
Kevin Simpson
One day Google is front of the AI race with Gemini. Now, it's Meta. Next, Anthropic and openAI. What makes Meta different is the AI is purely targeting the consumer. He has a large position and may sell part of it. The CEO is the original founder, which also makes him distinct from its peers. It's near record highs.
The overhang is that, despite good numbers from their ad business and AI's impact, Meta is still spending a lot building data centres--can Meta earn good returns on all those centres? However, Muse shows they can build productive things with AI. Despite the recent rally, he'd still buy it.
They're still generating huge amounts of cash despite all their AI spending. Trades at only 20x PE and down 2% this year after a huge run in 2025. Doesn't know if their paid subscriptions will work or not. But they keep doing things efficiently and ahead of the curve. They get things right without being overly aggressive. Their ad business remains huge.
In the space of just one week--SVB and Credit Suisse meltowns--we've gone from expecting the Fed from raising rates by 0.5% to cutting. It will be the most-anticipated Fed meeting (next week) in recent meeting. The next move is significant, and we don't know what. Their dilemma: raise or cut? When rates move up, it's hard to make money in stocks. Today, you had to buy food, drug and senior tech stocks like Meta. Drug stocks do well in recessions and pay dividends. Meta just announced a second round of mass layoffs. Billions of dollars in expenses will come out of Meta, while revenue will remain the same. Shares rallied yesterday and today and it's not done yet.